• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Asia

BioWorld Asia

July 25, 2018

View Archived Issues

Clinical data for July 17 – 23, 2018

Read More

Frontier gets priority nod for novel once-weekly HIV treatment in China

HONG KONG – The China National Drug Administration (CNDA) has approved the first domestically developed HIV drug. Known as Aikening (albuvirtide for injection), the novel drug was developed by Frontier Biotechnologies Inc., of Nanjing, to treat HIV-1 infection. Read More

Mesoblast carves out China deal with Tasly for CV stem cell candidates

PERTH, Australia – Mesoblast Ltd. has signed a deal with China's Tasly Pharmaceutical Group that opens up the massive greater China market to the Aussie stem cell company to develop, manufacture and commercialize two of its late-stage allogeneic mesenchymal precursor cell (MPC) candidates for cardiovascular indications. Read More

Chinese rabies vaccine maker halts production amid data falsification allegations

HONG KONG – Changchun Changsheng Life Sciences Ltd., China's second largest rabies vaccine producer, was ordered to stop production and recall batches of its rabies vaccines after the China National Drug Administration (CNDA) reportedly uncovered falsified data and inspection records. Read More

Regulatory actions for July 17 – 23, 2018

Read More

Precision med, clinical research a priority in Taiwan's biotech boost

TAIPEI, Taiwan – Precision medicine was a big topic at BioTaiwan, with one very local case study highlighting the promise of both the evolving field, as well as Taiwan's role as a clinical research location – a role the government is seeking to expand. Read More

Hainan Haiyao ready to acquire antibiotics maker Haikou Qili

HONG KONG – In the wake of a canceled anti-monopoly probe, Chinese drugmaker Hainan Haiyao Co. Ltd. plans to acquire Haikou Qili Pharmacy Co. Ltd. for ¥2.142 billion (US$322 million). Read More

Other news to note

Beigene Ltd., of Beigene, China, said it attended a hearing before the listing committee of the Stock Exchange of Hong Kong Ltd. (HKEX) in connection with its application to list its ordinary shares on the main board of HKEX. Read More

Appointments & advancements

Cstone Pharmaceuticals Co. Ltd., of Sozhou, China, appointed Richard Yeh chief financial officer. Yeh has over 20 years of experience working for investment banks and multinational biopharmaceutical companies.  Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 27, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 27, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 24, 2025
  • BIO2025: John Crowley and Martin Makary

    BIO 2025: Makary lays out FDA’s path, launches pilot review program

    BioWorld
    On the same day that FDA Commissioner Martin Makary spoke in a fireside chat during the 2025 Biotechnology Innovation Organization’s International Convention, the...
  • Andembry

    New orphan drug, CSL’s garadacimab, cleared for hereditary angioedema

    BioWorld
    Following a complete response letter issued last October over CMC issues, CSL Behring LLC gained U.S. FDA approval June 16 of its humanized anti-factor XIIa...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe